8 Related guidance

8 Related guidance

8.1 The Institute issued guidance in May 2002 on the use of GH treatment in children with growth failure.

  • National Institute for Clinical Excellence (2000) Guidance on the use of human growth hormone (somatropin) in children with growth failure. NICE Technology Appraisal Guidance No. 42. London: National Institute for Clinical Excellence. [Replaced by NICE Technology Appraisal Guidance 188]